Financhill
Buy
77

AINPF Quote, Financials, Valuation and Earnings

Last price:
$32.97
Seasonality move :
-24.52%
Day range:
$32.97 - $32.97
52-week range:
$32.97 - $64.70
Dividend yield:
1.69%
P/E ratio:
16.49x
P/S ratio:
0.32x
P/B ratio:
1.23x
Volume:
--
Avg. volume:
--
1-year change:
-49.04%
Market cap:
$1.2B
Revenue:
$3B
EPS (TTM):
$2.00
Period Ending 2021-04-30 2022-04-30 2023-04-30 2024-04-30 2025-04-30
Revenue $2.8B $2.8B $2.6B $2.7B $3B
Revenue Growth (YoY) 3.76% -0.71% -5.2% 3.74% 10.14%
 
Cost of Revenues $2.4B $2.4B $2.3B $2.4B $2.6B
Gross Profit $383.7M $392.2M $352.1M $365M $432.6M
Gross Profit Margin 13.7% 14.11% 13.36% 13.35% 14.36%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $317.8M $292.3M $260.7M $249.9M $358.7M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $282.4M $259.1M $234.8M $225.9M $321.3M
Operating Income $101.3M $133.1M $117.3M $139.1M $111.2M
 
Net Interest Expenses $414.5K $334.1K $382.1K $266.8K $1.7M
EBT. Incl. Unusual Items $110.8M $115.4M $116.7M $130.5M $110.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $47.8M $53M $48.8M $52.5M $49M
Net Income to Company $110.8M $115.4M $116.7M $130.5M $110.2M
 
Minority Interest in Earnings -$84.8K $70.3K $66.1K $47.9K $46.2K
Net Income to Common Excl Extra Items $63M $62.4M $67.9M $78M $61.1M
 
Basic EPS (Cont. Ops) $1.78 $1.77 $1.93 $2.22 $1.74
Diluted EPS (Cont. Ops) $1.78 $1.77 $1.93 $2.22 $1.74
Weighted Average Basic Share $35.4M $35.2M $35.1M $35.1M $35M
Weighted Average Diluted Share $35.4M $35.2M $35.1M $35.1M $35M
 
EBITDA $183M $211.5M $189.6M $213.6M $204.7M
EBIT $101.3M $133.1M $117.3M $139.1M $111.2M
 
Revenue (Reported) $2.8B $2.8B $2.6B $2.7B $3B
Operating Income (Reported) $101.3M $133.1M $117.3M $139.1M $111.2M
Operating Income (Adjusted) $101.3M $133.1M $117.3M $139.1M $111.2M
Period Ending 2021-10-31 2022-10-31 2023-10-31 2024-10-31 2025-10-31
Revenue $702.3M $633.4M $672.4M $759.3M $1.1B
Revenue Growth (YoY) 0.38% -9.81% 6.16% 12.92% 47.53%
 
Cost of Revenues $596.2M $547.1M $573.5M $652M $963.1M
Gross Profit $106.1M $86.4M $98.9M $107.2M $157.1M
Gross Profit Margin 15.11% 13.64% 14.7% 14.13% 14.02%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $77.6M $65.7M $64M $95.9M $136.1M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $77.6M $57.9M $64M $86M $115M
Operating Income $28.5M $28.5M $34.9M $21.3M $42M
 
Net Interest Expenses $99.1K $91.8K $61.1K $539.1K $5.2M
EBT. Incl. Unusual Items $30.3M $29.4M $37.2M $22.8M $36.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $12M $14.7M $16.1M $12.1M $19M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -$54K -$56.5K -$67.9K -$20.5K $147.7K
Net Income to Common Excl Extra Items $18.2M $14.8M $21.1M $10.7M $17.4M
 
Basic EPS (Cont. Ops) $0.52 $0.42 $0.60 $0.31 $0.49
Diluted EPS (Cont. Ops) $0.52 $0.42 $0.60 $0.31 $0.49
Weighted Average Basic Share $35.2M $35.1M $35.1M $35M $35.1M
Weighted Average Diluted Share $35.2M $35.1M $35.1M $35M $35.1M
 
EBITDA $47.8M $45.7M $52.6M $44.9M $81.4M
EBIT $28.5M $28.5M $34.9M $21.3M $42M
 
Revenue (Reported) $702.3M $633.4M $672.4M $759.3M $1.1B
Operating Income (Reported) $28.5M $28.5M $34.9M $21.3M $42M
Operating Income (Adjusted) $28.5M $28.5M $34.9M $21.3M $42M
Period Ending 2021-10-31 2022-10-31 2023-10-31 2024-10-31 2025-10-31
Revenue $2.8B $2.6B $2.7B $2.8B $3.6B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $2.4B $2.3B $2.3B $2.4B $3.1B
Gross Profit $440.1M $389.4M $406.4M $388.2M $567.3M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $321.9M $284.5M $277.3M $295.4M $477.4M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $321.9M $260.4M $277.3M $271M $423.6M
Operating Income $118.3M $129M $129.1M $117.2M $143.6M
 
Net Interest Expenses $389.3K $335.3K $303.9K $718.2K $7.1M
EBT. Incl. Unusual Items $123.2M $112.7M $130.1M $109.3M $130.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $54.6M $52.5M $53.3M $46.7M $60M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -$4K $91K $39.3K $77.8K $265.2K
Net Income to Common Excl Extra Items $68.6M $60.2M $76.8M $62.6M $70.4M
 
Basic EPS (Cont. Ops) $1.94 $1.71 $2.19 $1.78 $2.00
Diluted EPS (Cont. Ops) $1.94 $1.71 $2.19 $1.78 $2.00
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $197.9M $203.6M $203M $197.6M $262.5M
EBIT $118.3M $129M $129.1M $117.2M $143.6M
 
Revenue (Reported) $2.8B $2.6B $2.7B $2.8B $3.6B
Operating Income (Reported) $118.3M $129M $129.1M $117.2M $143.6M
Operating Income (Adjusted) $118.3M $129M $129.1M $117.2M $143.6M
Period Ending 2021-10-31 2022-10-31 2023-10-31 2024-10-31 2025-10-31
Revenue $1.4B $1.2B $1.3B $1.4B $2B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $1.2B $1.1B $1.2B $1.2B $1.7B
Gross Profit $206.8M $166.3M $193.3M $182.4M $295.9M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $154.5M $132.5M $132.6M $160.6M $257M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $154.5M $117.1M $132.6M $143.6M $224.6M
Operating Income $52.3M $49.1M $60.7M $38.8M $71.3M
 
Net Interest Expenses $199.3K $197K $118.3K $570.9K $5.9M
EBT. Incl. Unusual Items $54.9M $51.9M $65.4M $44.4M $65.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $24.8M $24.4M $29M $23.2M $34.5M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -$90.4K -$56.5K -$89.4K -$52.3K $161.4K
Net Income to Common Excl Extra Items $30.1M $27.6M $36.4M $21.1M $30.6M
 
Basic EPS (Cont. Ops) $0.86 $0.79 $1.04 $0.60 $0.87
Diluted EPS (Cont. Ops) $0.86 $0.79 $1.04 $0.60 $0.87
Weighted Average Basic Share $70.5M $70.3M $70.3M $70M $70.2M
Weighted Average Diluted Share $70.5M $70.3M $70.3M $70M $70.2M
 
EBITDA $90.1M $83.2M $96.3M $80.4M $138.1M
EBIT $52.3M $49.1M $60.7M $38.8M $71.3M
 
Revenue (Reported) $1.4B $1.2B $1.3B $1.4B $2B
Operating Income (Reported) $52.3M $49.1M $60.7M $38.8M $71.3M
Operating Income (Adjusted) $52.3M $49.1M $60.7M $38.8M $71.3M
Period Ending 2021-04-30 2022-04-30 2023-04-30 2024-04-30 2025-04-30
Cash and Equivalents $505.7M $461M $343.7M $308.9M $188.5M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $123.3M $78M $97.3M $100.7M $156.3M
Inventory $130.7M $114.2M $158.5M $156.6M $252.9M
Prepaid Expenses -- -- -- -- --
Other Current Assets $36.2M $30.8M $31.9M $35.1M $46.4M
Total Current Assets $881.9M $777.7M $722M $703.7M $790.9M
 
Property Plant And Equipment $276.6M $236.5M $289.8M $276.1M $348.5M
Long-Term Investments $28.5M $20.8M $22.9M $24.1M $25.6M
Goodwill $358.6M $279.9M $340.7M $281.9M $595.6M
Other Intangibles $33.1M $37.5M $43.3M $45.9M $90.3M
Other Long-Term Assets $59.3M $69.4M $56.5M $53.3M $64M
Total Assets $1.9B $1.6B $1.7B $1.6B $2.2B
 
Accounts Payable $427.8M $391.8M $431.1M $416.3M $567.1M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $169.9M $159.7M $172.6M $165.4M $209.6M
Total Current Liabilities $678.5M $631.4M $682.9M $656M $925.7M
 
Long-Term Debt $76.2M $45M $37.1M $20.7M $186.3M
Capital Leases -- -- -- -- --
Total Liabilities $803.5M $721.3M $772.6M $724.4M $1.2B
 
Common Stock $200.3M $169M $160.8M $139.1M $153.5M
Other Common Equity Adj -- -- -- -- --
Common Equity $1.1B $917.9M $928.7M $859.8M $999.2M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $713.6K $663.8K $705K $660.9K $778.2K
Total Equity $1.1B $918.6M $929.4M $860.5M $999.9M
 
Total Liabilities and Equity $1.9B $1.6B $1.7B $1.6B $2.2B
Cash and Short Terms $505.7M $461M $343.7M $308.9M $188.5M
Total Debt $110.6M $65.5M $64.2M $42.9M $233.8M
Period Ending 2021-10-31 2022-10-31 2023-10-31 2024-10-31 2025-10-31
Cash and Equivalents $514.7M $314.3M $333.6M $178.7M $345M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $87.1M $81.7M $90.1M $111.2M $284.5M
Inventory $143.1M $144.2M $164.1M $228.1M $299.3M
Prepaid Expenses -- -- -- -- --
Other Current Assets $21.7M $21.1M $22.9M $28.4M --
Total Current Assets $864.4M $661.3M $714.5M $668.6M $1.1B
 
Property Plant And Equipment $274.2M $248.3M $268.6M $320.4M $400.5M
Long-Term Investments $21.3M $18.9M $19.1M $20.3M $27.6M
Goodwill $343.2M $327.4M $299.4M $546.2M --
Other Intangibles $35.5M $36.1M $42.5M $79.5M --
Other Long-Term Assets $65.1M $69.6M $59.7M $59.6M --
Total Assets $1.8B $1.6B $1.6B $1.9B $3.3B
 
Accounts Payable $451.3M $408.5M $439.5M $495.7M $716M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $180.1M $140.9M $160.2M $184.8M --
Total Current Liabilities $718.8M $627.8M $678.3M $785.6M $2.1B
 
Long-Term Debt $60.2M $67.5M $19.8M $189M $228.2M
Capital Leases -- -- -- -- --
Total Liabilities $829.9M $741.9M $746.6M $1B $2.4B
 
Common Stock $192M $147.3M $144.6M $143.7M $142.1M
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $596.4K $524.8K $548.1K $623.7K $3.8M
Total Equity $1B $813.2M $857.4M $893.8M $944.4M
 
Total Liabilities and Equity $1.8B $1.6B $1.6B $1.9B $3.3B
Cash and Short Terms $514.7M $314.3M $333.6M $178.7M $345M
Total Debt $60.2M $67.5M $19.8M $189M $228.2M
Period Ending 2021-04-30 2022-04-30 2023-04-30 2024-04-30 2025-04-30
Net Income to Stockholders $110.8M $115.4M $116.7M $130.5M $110.2M
Depreciation & Amoritzation $81.8M $78.5M $72.3M $74.5M $93.4M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$781.9K $15.3M $13.2M -$41.6M -$36.7M
Change in Inventories $11M -$1.5M -$36.4M -$20M -$25.1M
Cash From Operations $140.6M $230M $148.9M $157.5M $152.6M
 
Capital Expenditures $54.1M $74M $89.3M $85.6M $80.3M
Cash Acquisitions $9.4M $20.4M $107.4M $12.1M $339.3M
Cash From Investing -$89.4M -$122.6M -$163.8M -$107.7M -$434.7M
 
Dividends Paid (Ex Special Dividend) $18.4M $17.1M $14.2M $14.4M $18.6M
Special Dividend Paid
Long-Term Debt Issued $119M $2.6M $73.7K $14M $211.7M
Long-Term Debt Repaid -$64M -$33.8M -$63.1M -$28.8M -$89.3M
Repurchase of Common Stock $9.4K $17.7M -- $16.7M --
Other Financing Activities -$18.9K -$2.1M -$2M -$178.1K -$3.8M
Cash From Financing $34.3M -$68.2M -$82.6M -$35M $138.8M
 
Beginning Cash (CF) $503.3M $459M $339.4M $307.4M $186.9M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $85.5M $39.2M -$97.5M $14.8M -$143.3M
Ending Cash (CF) $588.8M $498.2M $242M $322.3M $43.6M
 
Levered Free Cash Flow $86.5M $156M $59.6M $71.8M $72.3M
Period Ending 2021-10-31 2022-10-31 2023-10-31 2024-10-31 2025-10-31
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) $512.5M $292.8M $332M $178.6M $343.1M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2008-01-31 2009-01-31 2010-01-31 2011-01-31 2012-01-31
Net Income to Stockholders -- -- -- $85M --
Depreciation & Amoritzation -- -- $28.5M $27.7M --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -$46.3M --
Change in Inventories -- -- -- -$15M --
Cash From Operations -- -- $77.8M $90.7M --
 
Capital Expenditures -- $10.5M $14.9M $19M $5.2M
Cash Acquisitions -- -- -- $2.2M --
Cash From Investing -- -- -$7.6M -$50.1M --
 
Dividends Paid (Ex Special Dividend) -- -- $4M $6.3M --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- $5.5K --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -$11.3M $49.4M --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- $58.8M $89.9M --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- $62.9M $71.6M --
Period Ending 2021-10-31 2022-10-31 2023-10-31 2024-10-31 2025-10-31
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) $1B $643.4M $665.4M $506.9M $649.9M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Sell
30
CORT alert for Jan 1

Corcept Therapeutics, Inc. [CORT] is down 50.44% over the past day.

Buy
75
AXSM alert for Jan 1

Axsome Therapeutics, Inc. [AXSM] is up 22.82% over the past day.

Sell
50
NUTX alert for Jan 1

Nutex Health, Inc. [NUTX] is down 9.81% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock